FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Schrader

Research Profile

Disorders

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Chemicals & Drugs

Anatomy

Testis

Physiology

Concepts & Ideas

Neoplasm Staging

Co-author Network

Publications

TOP 3
B Nitzsche; Mark Schrader; F Zengerling; Stefan Balabanov; C Gloesenkamp; B Hoffmann; Friedemann Honecker; Michael Höpfner
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Christoph Gloesenkamp; Alice R Lim; Bianca Nitzsche; Emmanuel Normant; Matthias Ocker; Hans Scherübl; Mark Schrader; Evan Vosburgh; Michael Höpfner
Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
Friedemann Zengerling; Marcus V Cronauer; Bianca Nitzsche; Andres J Schrader; Mark Schrader; Wolfgang Streicher; Michael Höpfner
Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Schrader (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: B Nitzsche; Mark Schrader; F Zengerling; Stefan Balabanov; C Gloesenkamp; B Hoffmann; Friedemann Honecker; Michael Höpfner
Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
British journal of cancer 2012;107(11):1853-63.
2012: Christoph Gloesenkamp; Alice R Lim; Bianca Nitzsche; Emmanuel Normant; Matthias Ocker; Hans Scherübl; Mark Schrader; Evan Vosburgh; Michael Höpfner
Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.
International journal of oncology 2012;40(5):1659-67.
2012: Friedemann Zengerling; Marcus V Cronauer; Bianca Nitzsche; Andres J Schrader; Mark Schrader; Wolfgang Streicher; Michael Höpfner
Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells.
International journal of molecular sciences 2012;13(9):11530-42.
2012: Jonas Busch; Barbara Erber; Frank Friedersdorff; Ivan Hoffmann; Carsten Kempkensteffen; Ahmed Magheli; Kurt Miller; Mark Schrader; Steffen Weikert; Stefan Hinz
Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis.
BMC urology 2012;12():15.
2012: Barbara Erber; Daniel Baumunk; Anja Lingnau; Kurt Miller; Martin Schostak; Andres Jan Schrader; Mark Schrader; Florian Jentzmik
Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder.
ISRN urology 2012;2012():342796.
2011: Carsten Stephan; Kurt Miller; Mark Schrader; Kerstin Siemssen; Henning Cammann; Serdar Deger; Frank Friedersdorff; Klaus Jung; Michael Lein; Hellmuth-Alexander Meyer
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomograms.
Clinical chemistry 2011;57(7):995-1004.
2010: Stefan Hinz; Ahmed Magheli; Steffen Weikert; Wolfgang Schulze; Hans Krause; Mark Schrader; Kurt Miller; Carsten Kempkensteffen
Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.
World journal of urology 2010;28(5):631-5.
2010: Florian Jentzmik; Martin Schostak; Carsten Stephan; Daniel Baumunk; Anja Lingnau; Steffen Weikert; Michael Lein; Kurt Miller; Mark Schrader
Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique.
World journal of urology 2010;28(4):457-63.
2010: Florian Jentzmik; Carsten Stephan; Kurt Miller; Mark Schrader; Andreas Erbersdobler; Glen Kristiansen; Michael Lein; Klaus Jung
Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.
European urology 2010;58(1):12-8; discussion 20-1.
2010: B Nitzsche; C Gloesenkamp; Mark Schrader; M Ocker; R Preissner; Michael Lein; Andreas Zakrzewicz; B Hoffmann; Michael Höpfner
Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours.
British journal of cancer 2010;103(1):18-28.
2010: Mark Schrader; Lothar Weissbach; Michael Hartmann; Susanne Krege; Peter Albers; Kurt Miller; Axel Heidenreich
Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer?
European urology 2010;57(5):867-72.
2010: Romy Strenziok; Stefan Hinz; Christian Wolf; Tim Conrad; Hans Krause; Kurt Miller; Mark Schrader
Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients.
World journal of urology 2010;28(2):193-7.
2010: J Busch; C Röllig; Lothar Weissbach; Carsten Kempkensteffen; Stefan Hinz; Cosima Jahnke; Martin Schostak; Michael Lein; Steffen Weikert; Carsten Stephan; Serdar Deger; G Ollenschläger; Kurt Miller; Mark Schrader
[What is most important is what comes across : Urological guidelines from the target group's point of view].
Der Urologe. Ausg. A 2010;49(1):75-80.
2010: Annika Schaefer; Monika Jung; Glen Kristiansen; Michael Lein; Mark Schrader; Kurt Miller; Carsten Stephan; Klaus Jung
MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Urologic oncology 2010;28(1):4-13.
2009: Stefan Hinz; Soroush Rais-Bahrami; Wolf H Weiske; Carsten Kempkensteffen; Mark Schrader; Kurt Miller; Ahmed Magheli
Prognostic value of intraoperative parameters observed during vasectomy reversal for predicting postoperative vas patency and fertility.
World journal of urology 2009;27(6):781-85.
2009: Carsten Stephan; Henning Cammann; Serdar Deger; Mark Schrader; Hellmuth-Alexander Meyer; Kurt Miller; Michael Lein; Klaus Jung
Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
Urology 2009;74(4):873-7.
2009: Anne Schaefer; M Jung; G Kristiansen; M Lein; Mark Schrader; Kurt Miller; A Erbersdobler; C Stephan; K Jung
[MicroRNA in uro-oncology : New hope for the diagnosis and treatment of tumors?].
Der Urologe. Ausg. A 2009;48(8):877-85.
2009: Carsten Stephan; Harry Rittenhouse; Henning Cammann; Michael Lein; Mark Schrader; Serdar Deger; Kurt Miller; Klaus Jung
New markers and multivariate models for prostate cancer detection.
Anticancer research 2009;29(7):2589-600.
2009: Florian Thilo; Daniel Baumunk; Hans Krause; Mark Schrader; Kurt Miller; Christoph Loddenkemper; Andreas Zakrzewicz; Katharina Krueger; Walter Zidek; Martin Tepel
Transient receptor potential canonical type 3 channels and blood pressure in humans.
Journal of hypertension 2009;27(6):1217-23.
2009: Michael Lein; Kurt Miller; Manfred Wirth; Lothar Weissbach; Christoph May; Katja Schmidt; Ulrike Haus; Mark Schrader; Klaus Jung
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
The Prostate 2009;69(6):624-32.
2009: Mark Schrader; Michael Hartmann; S Krege; A Heidenreich; Kurt Miller; Lothar Weissbach
[Testicular germ cell cancer : interdependence between guidelines and a second-opinion system].
Der Urologe. Ausg. A 2009;48(4):393-8.
2009: Carsten Stephan; Anna-Maria Kahrs; Henning Cammann; Michael Lein; Mark Schrader; Serdar Deger; Kurt Miller; Klaus Jung
A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
The Prostate 2009;69(2):198-207.
2009: Carsten Stephan; Thomas Köpke; Axel Semjonow; Michael Lein; Serdar Deger; Mark Schrader; Kurt Miller; Klaus Jung
Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1325-31.
2009: Carsten Kempkensteffen; Stefan Hinz; Manfred Johannsen; Hans Krause; Ahmed Magheli; Frank Christoph; Jens Köllermann; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression of Mcl-1 splicing variants in clear-cell renal cancer and their correlation with histopathological parameters and prognosis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(2):73-9.
2009: Mark Schrader; Carsten Kempkensteffen; Frank Christoph; Stefan Hinz; Steffen Weikert; Michael Lein; Hans Krause; Carsten Stephan; Klaus Jung; Michael Hoepfner; Peter Albers; Kurt Miller; Martin Schostak
Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy options.
Oncology 2009;76(2):77-84.
2008: Carsten Kempkensteffen; Stefan Hinz; T Jäger; Steffen Weikert; Hans Krause; Martin Schostak; Frank Christoph; R Strenziok; Kurt Miller; Mark Schrader
[Expression levels of the IAP antagonists XAF1, Smac/DIABLO and HtrA2 in testicular germ cell tumours].
Aktuelle Urologie 2008;39(6):436-41.
2008: J Ebbing; Frank Christoph; Carsten Kempkensteffen; Steffen Weikert; Martin Schostak; Stefan Hinz; Michael Lein; Kurt Miller; Mark Schrader
[Testicular cancer - explanatory models for high cisplatin chemosensibility and new therapeutic options].
Aktuelle Urologie 2008;39(6):429-35.
2008: Klaus Jung; Azizbek Ramankulov; Mark Schrader; Kurt Miller; Michael Lein
Circulating matrix metalloproteinase-7: an early or metastatic marker for renal cell carcinoma?
Clinical chemistry 2008;54(11):1927-9.
2008: Kurt Miller; Michael Lein; Martin Schostak; Mark Schrader
[Adjuvant and neoadjuvant drug therapy for prostate cancer].
Der Urologe. Ausg. A 2008;47(11):1460-4.
2008: Azizbek Ramankulov; Michael Lein; Manfred Johannsen; Mark Schrader; Kurt Miller; Stefan A Loening; Klaus Jung
Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma.
Cancer letters 2008;269(1):85-92.
2008: Azizbek Ramankulov; Michael Lein; Manfred Johannsen; Mark Schrader; Kurt Miller; Klaus Jung
Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas.
Cancer science 2008;99(6):1188-94.
2008: Carsten Kempkensteffen; Stefan Hinz; Frank Christoph; Hans Krause; Ahmed Magheli; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
Journal of cancer research and clinical oncology 2008;134(5):543-50.
2008: Stefan Hinz; Mark Schrader; Carsten Kempkensteffen; Roland Bares; Winfried Brenner; Susanne Krege; Christiane Franzius; Sabine Kliesch; Ruediger Heicappel; Kurt Miller; Maike de Wit
The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma.
The Journal of urology 2008;179(3):936-40; discussion 940.
2008: Stefan Hinz; Carsten Kempkensteffen; Frank Christoph; Michèle Hoffmann; Hans Krause; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder.
Journal of cancer research and clinical oncology 2008;134(3):331-6.
2008: Frank Christoph; Stefan Hinz; Steffen Weikert; Carsten Kempkensteffen; Martin Schostak; Kurt Miller; Mark Schrader
Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
Urologia internationalis 2008;80(4):398-404.
2008: Martin Schostak; Kurt Miller; Mark Schrader
Hormone therapy for prostate cancer - immediate initiation.
Frontiers of radiation therapy and oncology 2008;41():49-57.
2008: Martin Schostak; Kurt Miller; Mark Schrader
Radical prostatectomy in the 21st century - the gold standard for localized and locally advanced prostate cancer.
Frontiers of radiation therapy and oncology 2008;41():7-14.
2008: Carsten Kempkensteffen; Stefan Hinz; Hans Krause; Tobias Jager; Jens Köllermann; Steffen Weikert; Frank Christoph; Martin Schostak; Kurt Miller; Mark Schrader
Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(2):76-82.
2007: Frank Christoph; Stefan Hinz; Carsten Kempkensteffen; Martin Schostak; Mark Schrader; Kurt Miller
mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
The Journal of urology 2007;178(6):2655-9.
2007: Martin Schostak; C Braun; Hans Krause; Kurt Miller; Carsten Kempkensteffen; Stefan Hinz; R Strenziok; A Blana; Mark Schrader
[New polymorphisms in the PSA promoter in patients with prostate carcinoma].
Aktuelle Urologie 2007;38(6):465-72.
2007: Carsten Kempkensteffen; Tobias Jäger; Johannes Bub; Steffen Weikert; Stefan Hinz; Frank Christoph; Hans Krause; Martin Schostak; Kurt Miller; Mark Schrader
The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours.
International journal of andrology 2007;30(5):476-83.
2007: Carsten Kempkensteffen; Stefan Hinz; Mark Schrader; Frank Christoph; Ahmed Magheli; Hans Krause; Martin Schostak; Kurt Miller; Steffen Weikert
Gene expression and promoter methylation of the XIAP-associated Factor 1 in renal cell carcinomas: correlations with pathology and outcome.
Cancer letters 2007;254(2):227-35.
2007: H Krause; Mark Schrader; Kurt Miller
[Molecular translational research--a juxtaposition of international developments and personal research approaches].
Der Urologe. Ausg. A 2007;46(9):1163-5.
2007: Martin Schostak; Hans Krause; Kurt Miller; Mark Schrader; Carsten Kempkensteffen; Jens Kollermann
Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.
BJU international 2007;99(6):1409-14.
2007: Frank Christoph; Stefan Hinz; Carsten Kempkensteffen; Steffen Weikert; Hans Krause; Martin Schostak; Mark Schrader; Kurt Miller
A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer.
Journal of cancer research and clinical oncology 2007;133(6):343-9.
2007: Frank Christoph; Carsten Kempkensteffen; Steffen Weikert; Hans Krause; Martin Schostak; Kurt Miller; Mark Schrader
Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.
Cancer letters 2007;247(1):137-42.
2007: Carsten Kempkensteffen; Stefan Hinz; Frank Christoph; Jens Köllermann; Hans Krause; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance.
International journal of cancer. Journal international du cancer 2007;120(5):1081-6.
2007: Frank Christoph; Steffen Weikert; Ingmar Wolff; Martin Schostak; Karim Tabiti; Markus Müller; Kurt Miller; Mark Schrader
Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
Cancer letters 2007;245(1-2):121-6.
2007: Frank Christoph; A Moschkowitsch; Carsten Kempkensteffen; Martin Schostak; Kurt Miller; Mark Schrader
Long-term efficacy of tolterodine and patient compliance in pediatric patients with neurogenic detrusor overactivity.
Urologia internationalis 2007;79(1):55-9.
2007: Stefan Hinz; Carsten Kempkensteffen; Steffen Weikert; Martin Schostak; Mark Schrader; Kurt Miller; Frank Christoph
EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(3):151-7.
2007: Carsten Kempkensteffen; Stefan Hinz; Frank Christoph; Hans Krause; Jens Koellermann; Ahmed Magheli; Mark Schrader; Martin Schostak; Kurt Miller; Steffen Weikert
Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(3):132-8.
2006: Frank Christoph; Carsten Kempkensteffen; Steffen Weikert; Jens Köllermann; Hans Krause; K Miller; Martin Schostak; Mark Schrader
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.
British journal of cancer 2006;95(12):1701-7.
2006: Carsten Kempkensteffen; Frank Christoph; Steffen Weikert; Hans Krause; Jens Köllermann; Martin Schostak; Kurt Miller; Mark Schrader
Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors.
Journal of cancer research and clinical oncology 2006;132(12):765-70.
2006: Frank Christoph; Steffen Weikert; Carsten Kempkensteffen; Hans Krause; Martin Schostak; Kurt Miller; Mark Schrader
Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
International journal of cancer. Journal international du cancer 2006;119(6):1396-402.
2006: Frank Christoph; Steffen Weikert; Carsten Kempkensteffen; Hans Krause; Martin Schostak; Jens Köllermann; Kurt Miller; Mark Schrader
Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5040-6.
2006: Carsten Kempkensteffen; Stefan Hinz; Frank Christoph; Steffen Weikert; Mark Schrader; Martin Schostak
[Rectal perforation as a late complication of ProACT implantation].
Der Urologe. Ausg. A 2006;45(7):865-7.
2006: Mark Schrader; M Hartmann; Susanne Krege; K Miller; Lothar Weissbach
["Second opinion centers". Approach for improving the quality of treatment for testicular tumors].
Der Urologe. Ausg. A 2006;45(4):493-4.
2006: Mark Schrader; Lothar Weissbach; Steffen Weikert; Martin Schostak; Kurt Miller
Paper tigers--do clinical guidelines improve health care quality in patients with testicular germ cell tumors in Germany?
Health policy (Amsterdam, Netherlands) 2006;75(3):338-46.
2006: Martin Schostak; Kurt Miller; Hans Krause; Mark Schrader; Carsten Kempkensteffen; Jens Kollermann
Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
Cancer detection and prevention 2006;30(5):449-54.
2006: Jens Kollermann; Carsten Kempkensteffen; Burkhard Helpap; Mark Schrader; Hans Krause; Markus Muller; Kurt Miller; Martin Schostak
Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
BMC urology 2006;6():15.
2006: Martin Schostak; Hans Krause; Kurt Miller; Mark Schrader; Steffen Weikert; Frank Christoph; Carsten Kempkensteffen; Jens Kollermann
Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.
BMC urology 2006;6():7.
2006: Steffen Weikert; Frank Christoph; Wolfgang Schulze; Hans Krause; Carsten Kempkensteffen; Martin Schostak; Kurt Miller; Mark Schrader
Testicular expression of survivin and human telomerase reverse transcriptase (hTERT) associated with spermatogenic function in infertile patients.
Asian journal of andrology 2006;8(1):95-100.
2005: Martin Schostak; K Matischak; M Schäfer; M Müller; Mark Schrader; Frank Christoph; Kurt Miller
[New concept minimizes bleeding in radical retropubic prostatectomy].
Der Urologe. Ausg. A 2005;44(11):1332-6.
2005: Steffen Weikert; Hans Krause; Ingmar Wolff; Frank Christoph; Mark Schrader; Thomas Emrich; Kurt Miller; Markus Müller
Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
International journal of cancer. Journal international du cancer 2005;117(2):274-80.
2005: Steffen Weikert; Frank Christoph; Markus Müller; Martin Schostak; Kurt Miller; Mark Schrader
Acucise endopyelotomy: a technique with limited efficacy for primary ureteropelvic junction obstruction in adults.
International journal of urology : official journal of the Japanese Urological Association 2005;12(10):864-8.
2005: Sven Diederichs; Nicole Bäumer; Nikolaus Schultz; F Kent Hamra; Mark Schrader; Marie-Luise Sandstede; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Expression patterns of mitotic and meiotic cell cycle regulators in testicular cancer and development.
International journal of cancer. Journal international du cancer 2005;116(2):207-17.
2005: Steffen Weikert; Frank Christoph; Mark Schrader; Hans Krause; Kurt Miller; Markus Müller
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
International journal of cancer. Journal international du cancer 2005;116(1):100-4.
2005: Steffen Weikert; Mark Schrader; Frank Christoph; Wolfgang Schulze; Hans Krause; Markus Müller; Kurt Miller
Quantification of survivin mRNA in testes of infertile patients and in testicular germ cell tumours: high levels of expression associated with normal spermatogenesis.
International journal of andrology 2005;28(4):224-9.
2005: Martin Schostak; Klaudia Matischak; Markus Müller; Michel Schäfer; Mark Schrader; Frank Christoph; Kurt Miller
New perioperative management reduces bleeding in radical retropubic prostatectomy.
BJU international 2005;96(3):316-9.
2005: Steffen Weikert; Frank Christoph; Jens Köllermann; Markus Müller; Mark Schrader; Kurt Miller; Hans Krause
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas.
International journal of molecular medicine 2005;16(2):349-53.
2005: Mark Schrader; Hans Krause; Steffen Weikert; Bernd Straub; Martin Schostak; Frank Christoph; Kurt Miller
Kinetic fluorescence RT-PCR is highly sensitive for detection of germ-cell-tumor-specific transcripts in peripheral blood.
International journal of molecular medicine 2005;16(1):143-7.
2005: Martin Schostak; Frank Christoph; Mark Schrader; M Panick; A Lingnau; Kurt Miller
[Prostate biopsy -- practical examination of the adequacy of Chen's virtual strategy].
Aktuelle Urologie 2005;36(2):149-53.
2005: Steffen Weikert; Mark Schrader; Markus Müller; Wolfgang Schulze; Hans Krause; Kurt Miller
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failure.
Fertility and sterility 2005;83 Suppl 1():1100-5.
2005: Frank Christoph; Steffen Weikert; Kurt Miller; Mark Schrader
New guidelines for clinical stage I testicular seminoma?
Oncology 2005;69(6):455-62.
2004: Frank Christoph; Mark Schrader; A Amirmaki; Kurt Miller
Acute scrotum due to arterial bleeding mimicking non-seminomatous germ cell tumor.
Asian journal of andrology 2004;6(4):379-81.
2004: Sven Diederichs; Nicole Bäumer; Ping Ji; Stephan K Metzelder; Gregory E Idos; Thomas Cauvet; Wenbing Wang; Maria Möller; Sarah Pierschalski; Jörg Gromoll; Mark Schrader; H Phillip Koeffler; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
The Journal of biological chemistry 2004;279(32):33727-41.
2004: Martin Schostak; H Wloch; M Müller; Mark Schrader; Gerd Offermann; K Miller
Optimizing open live-donor nephrectomy - long-term donor outcome.
Clinical transplantation 2004;18(3):301-5.
2004: Steffen Weikert; Mark Schrader; Markus Müller; Hans Krause; Kurt Miller
Expression of the apoptosis inhibitor survivin in testicular tissue of infertile patients.
International journal of andrology 2004;27(3):161-5.
2004: Mark Schrader; Lothar Weissbach; Markus Müller; Bernd Straub; Hans Krause; Carsten Goessl; Martin Schostak; Heike L Rittner; S Stange; Kurt Miller
Detection of germ-cell-tumor-specific gene products in peripheral blood by immunomagnetic tumor cell enrichment followed by RT-PCR.
International journal of molecular medicine 2004;13(5):685-90.
2003: Martin Schostak; H Wloch; M Müller; Mark Schrader; Frank Christoph; Gerd Offermann; Kurt Miller
Living donor nephrectomy in an open technique; a long-term analysis of donor outcome.
Transplantation proceedings 2003;35(6):2096-8.
2003: Bernd Straub; Markus Müller; Hans Krause; Mark Schrader; Kurt Miller
Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
Urology 2003;62(1):172-6.
2003: Bernd Straub; Markus Müller; Rüdiger Heicappell; Mark Schrader; Carsten Goessl; Kurt Miller
Hyperphosphaturia after kidney transplantation in syngeneic rats: effects on nephrocalcinosis and bone metabolism?
Transplantation proceedings 2003;35(4):1575-80.
2003: Carsten Müller-Tidow; Sven Diederichs; Mark Schrader; Ulf Vogt; Kurt Miller; Wolfgang E Berdel; Hubert Serve
Cyclin A1 is highly expressed in aggressive testicular germ cell tumors.
Cancer letters 2003;190(1):89-95.
2003: Mark Schrader; Markus Müller; N Sofikitis; Bernd Straub; Hans Krause; Kurt Miller
"Onco-tese": testicular sperm extraction in azoospermic cancer patients before chemotherapy-new guidelines?
Urology 2003;61(2):421-5.
2003: Bernd Straub; Markus Müller; Hans Krause; Mark Schrader; Kurt Miller
Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
Oncology 2003;65 Suppl 1():12-7.
2002: Mark Schrader; Angelika Burger; Markus Müller; Hans Krause; Bernd Straub; Martin Schostak; Wolfgang Schulze; Heidrun Lauke; Kurt Miller
The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase.
BMC cancer 2002;2():32.
2002: Mark Schrader; Carsten Müller-Tidow; Stuart Ravnik; Markus Müller; Wolfgang Schulze; Sven Diederichs; Hubert Serve; Kurt Miller
Cyclin A1 and gametogenesis in fertile and infertile patients: a potential new molecular diagnostic marker.
Human reproduction (Oxford, England) 2002;17(9):2338-43.
2002: Bernd Straub; Markus Muller; Hans Krause; Mark Schrader; Carsten Goessl; Kurt Miller
Receptor gene messenger RNA expression in metastatic lesions of prostate cancer.
The Journal of urology 2002;168(3):1212-4.
2002: Mark Schrader; Angelika Burger; Markus Müller; Hans Krause; Bernd Straub; Gilian L Smith; Eward S Newlands; Kurt Miller
Quantification of human telomerase reverse transcriptase mRNA in testicular germ cell tumors by quantitative fluorescence real-time RT-PCR.
Oncology reports 2002;9(5):1097-105.
2002: Bernd Straub; M Müller; Mark Schrader; Carsten Goessl; Rüdiger Heicappell; Kurt Miller
Intestinal and renal handling of oxalate in magnesium-deficient rats. Evaluation of intestinal in vivo 14C-oxalate perfusion.
BJU international 2002;90(3):312-6.
2002: Mark Schrader; Stuart Ravnik; Carsten Müller-Tidow; Markus Müller; Bernd Straub; Sven Diedrichs; Hubert Serve; Kurt Miller
Quantification of cyclin A1 and glyceraldehyde-3-phosphate dehydrogenase expression in testicular biopsies of infertile patients by fluorescence real-time RT-PCR.
International journal of andrology 2002;25(4):202-9.
2002: Bernd Straub; Markus Müller; Hans Krause; Carsten Goessl; Mark Schrader; Rüdiger Heicappell; Kurt Miller
Molecular staging of pelvic surgical margins after radical prostatectomy: comparison of RT-PCR for prostate-specific antigen and telomerase activity.
Oncology reports 2002;9(3):545-9.
2002: Mark Schrader; Markus Müller; N Sofikitis; Bernd Straub; Kurt Miller
Testicular sperm extraction in azoospermic cancer patients prior to treatment--a new guideline?
Human reproduction (Oxford, England) 2002;17(4):1127-8.
2002: Mark Schrader; Markus Muller; Bernd Straub; Kurt Miller
Testicular sperm extraction in azoospermic patients with gonadal germ cell tumors prior to chemotherapy--a new therapy option.
Asian journal of andrology 2002;4(1):9-15.
2002: Mark Schrader; Markus Müller; N Sofikitis; Carsten Goessl; Bernd Straub; Kurt Miller
Testicular sperm extraction prior to treatment in azoospermic patients with Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):333.
2002: Mark Schrader; Markus Müller; W Schulze; Rüdiger Heicappell; Hans Krause; Bernd Straub; Kurt Miller
Quantification of telomerase activity, porphobilinogen deaminase and human telomerase reverse transcriptase mRNA in testicular tissue - new parameters for a molecular diagnostic classification of spermatogenesis disorders.
International journal of andrology 2002;25(1):34-44.
2002: Mark Schrader; Markus Müller; Wolfgang Schulze; Rüdiger Heicappell; Hans Krause; Bernd Straub; Kurt Miller
Quantification of the expression level of the gene encoding the catalytic subunit of telomerase in testicular tissue specimens predicts successful sperm recovery.
Human reproduction (Oxford, England) 2002;17(1):150-6.
2001: Mark Schrader; Markus Müller; Rüdiger Heicappell; Bernd Straub; Kurt Miller
Quantification of human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) mRNA in testicular tissue of infertile patients.
Asian journal of andrology 2001;3(4):263-70.
2001: Bernd Straub; Markus Müller; Hans Krause; Mark Schrader; Carsten Goessl; Rüdiger Heicappell; Kurt Miller
Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
Urology 2001;58(5):815-20.
2001: Carsten Goessl; Markus Müller; Rüdiger Heicappell; Hans Krause; Bernd Straub; Mark Schrader; Kurt Miller
DNA-based detection of prostate cancer in urine after prostatic massage.
Urology 2001;58(3):335-8.
2001: Mark Schrader; Rüdiger Heicappell; Markus Müller; Bernd Straub; Kurt Miller
Impact of chemotherapy on male fertility.
Onkologie 2001;24(4):326-30.
2001: Bernd Straub; Markus Müller; Hans Krause; Mark Schrader; Carsten Goessl; Rüdiger Heicappell; Kurt Miller
Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2340-3.
2001: Bernd Straub; Markus Müller; Mark Schrader; Rüdiger Heicappell; Kurt Miller
Osteoporosis and mild metabolic acidosis in the rat after orchiectomy and their prevention: should prophylactic therapy be administered to patients with androgen deprivation?
The Journal of urology 2001;165(5):1783-9.
2001: Bernd Straub; Markus Müller; Hans Krause; Carsten Goessl; Mark Schrader; Rüdiger Heicappell; Kurt Miller
Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy.
Urology 2001;57(5):1006-11.
2000: Carsten Goessl; Hans Krause; Markus Müller; Rüdiger Heicappell; Mark Schrader; J Sachsinger; Kurt Miller
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.
Cancer research 2000;60(21):5941-5.
2000: Mark Schrader; Markus Müller; J Sachsinger; Rüdiger Heicappell; B Bergé; Hans Krause; Kurt Miller
Telomerase activity in testicular biopsy material.
Human reproduction (Oxford, England) 2000;15(9):2057-9.
2000: Bernd Straub; Markus Müller; Mark Schrader; Rüdiger Heicappell; R Hardung; Kurt Miller
Recurrent intraluminal ureteral metastasis of a testicular seminoma.
The Journal of urology 2000;164(2):443-4.
2000: Mark Schrader; Markus Müller; Rüdiger Heicappell; Hans Krause; Wolfgang Schulze; Kurt Miller
Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients.
Fertility and sterility 2000;73(4):706-11.